The Microbiome-Gut-Brain Axis in Health and Disease

Gastroenterology Clinics of North America

Volumn 46, Issue 1, 2017, Pages 77-89

  Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

GABA; Microbiota; Psychobiotics; Serotonin; Short chain fatty acids; Vagus nerve

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; PREBIOTIC AGENT; PROBIOTIC AGENT; 4 AMINOBUTYRIC ACID; CYTOKINE; TRYPTOPHAN; VOLATILE FATTY ACID;

ANXIETY; AUTISM; BACTEROIDES FRAGILIS; BACTEROIDETES; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; BLOOD BRAIN BARRIER; BRAIN INTESTINE FLORA AXIS; CYTOKINE PRODUCTION; DEPRESSION; DESULFOVIBRIO; DIETARY INTAKE; DISEASE SEVERITY; DYSBIOSIS; ENTEROBACTERIACEAE; FECES MICROFLORA; FERMENTED MILK PRODUCT; FIRMICUTES; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS CASEI; MENTAL STRESS; MICROBIAL DIVERSITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; POPULATION ABUNDANCE; PREVALENCE; PREVOTELLACEAE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; TRANQUILIZING ACTIVITY; ANIMAL; BRAIN; GASTROINTESTINAL TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; VAGUS NERVE;

ANIMALS; AUTISTIC DISORDER; BRAIN; CYTOKINES; DEPRESSION; FATTY ACIDS, VOLATILE; GAMMA-AMINOBUTYRIC ACID; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; IRRITABLE BOWEL SYNDROME; PARKINSON DISEASE; PREBIOTICS; PROBIOTICS; TRYPTOPHAN; VAGUS NERVE;

EID: 85008489711     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2016.09.007     Document Type: Review

References (61)

1. 1 Dinan, T.G., Stilling, R.M., Stanton, C., et al. Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res 63 (2015), 1–9.
2. 2 Stilling, R.M., Dinan, T.G., Cryan, J.F., Microbial genes, brain & behaviour - epigenetic regulation of the gut-brain axis. Genes Brain Behav 13:1 (2014), 69–86.
3. 3 Mayer, E.A., Knight, R., Mazmanian, S.K., et al. Gut microbes and the brain: paradigm shift in neuroscience. J Neurosci 34:46 (2014), 15490–15496.
4. 4 Rhee, S.H., Pothoulakis, C., Mayer, E.A., Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6:5 (2009), 306–314.
5. 5 El Aidy, S., Dinan, T.G., Cryan, J.F., Gut microbiota: the conductor in the orchestra of immune-neuroendocrine communication. Clin Ther 37:5 (2015), 954–967.
6. 6 Grenham, S., Clarke, G., Cryan, J.F., et al. Brain-gut-microbe communication in health and disease. Front Physiol, 2, 2011, 94.
7. 7 Bravo, J.A., Forsythe, P., Chew, M.V., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 108:38 (2011), 16050–16055.
8. 8 Svensson, E., Horvath-Puho, E., Thomsen, R.W., et al. Vagotomy and subsequent risk of Parkinson's disease. Ann Neurol 78:4 (2015), 522–529.
9. 9 Desbonnet, L., Garrett, L., Clarke, G., et al. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170:4 (2010), 1179–1188.
10. 10 Lyte, M., Microbial endocrinology in the microbiome-gut-brain axis: how bacterial production and utilization of neurochemicals influence behavior. PLoS Pathog, 9(11), 2013, e1003726.
11. 11 Lyte, M., Microbial endocrinology and the microbiota-gut-brain axis. Adv Exp Med Biol 817 (2014), 3–24.
12. 12 Canfora, E.E., Jocken, J.W., Blaak, E.E., Short-chain fatty acids in control of body weight and insulin sensitivity. Nat Rev Endocrinol 11:10 (2015), 577–591.
13. 13 El Aidy, S., Dinan, T.G., Cryan, J.F., Immune modulation of the brain-gut-microbe axis. Front Microbiol, 5, 2014, 146.
14. 14 Wang, Y., Kasper, L.H., The role of microbiome in central nervous system disorders. Brain Behav Immun 38 (2014), 1–12.
15. 15 Tillisch, K., The effects of gut microbiota on CNS function in humans. Gut microbes 5:3 (2014), 404–410.
16. 16 Scott, L.V., Clarke, G., Dinan, T.G., The brain-gut axis: a target for treating stress-related disorders. Mod Trends Pharmacopsychiatri 28 (2013), 90–99.
17. 17 Moloney, R.D., Desbonnet, L., Clarke, G., et al. The microbiome: stress, health and disease. Mamm Genome 25:1–2 (2014), 49–74.
18. 18 O'Mahony, S.M., Clarke, G., Dinan, T.G., et al. Early-life adversity and brain development: Is the microbiome a missing piece of the puzzle?. Neuroscience, 2015 [Epub ahead of print].
19. 19 O'Mahony, S.M., Hyland, N.P., Dinan, T.G., et al. Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology 214:1 (2011), 71–88.
20. 20 O'Mahony, S.M., Marchesi, J.R., Scully, P., et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatry 65:3 (2009), 263–267.
21. 21 Dinan, T.G., Quigley, E.M., Ahmed, S.M., et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?. Gastroenterology 130:2 (2006), 304–311.
22. 22 Marshall, J.K., Thabane, M., Garg, A.X., et al. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut 59:5 (2010), 605–611.
23. 23 Backhed, F., Programming of Host Metabolism by the Gut Microbiota. Ann Nutr Metab 58 (2011), 44–52.
24. 24 Eckburg, P.B., Bik, E.M., Bernstein, C.N., et al. Diversity of the human intestinal microbial flora. Science 308:5728 (2005), 1635–1638.
25. 25 Qin, J., Li, R., Raes, J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:7285 (2010), 59–65.
26. 26 Penders, J., Thijs, C., Vink, C., et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 118:2 (2006), 511–521.
27. 27 Dennison, B., Definition of preterm delivery. Br Med J, 2(6049), 1976, 1449.
28. 28 Hoy, C.M., Wood, C.M., Hawkey, P.M., et al. Duodenal microflora in very-low-birth-weight neonates and relation to necrotizing enterocolitis. J Clin Microbiol 38:12 (2000), 4539–4547.
29. 29 Sondheimer, J.M., Clark, D.A., Gastric pH in healthy preterm infants - effect of age and feeding type. Gastroenterology, 88(5), 1985, 1593.
30. 30 Sondheimer, J.M., Clark, D.A., Gervaise, E.P., Continuous gastric pH measurement in young and older healthy preterm infants receiving formula and clear liquid feedings. J Pediatr Gastroenterol Nutr 4:3 (1985), 352–355.
31. 31 Arboleya, S., Binetti, A., Salazar, N., et al. Establishment and development of intestinal microbiota in preterm neonates. FEMS Microbiol Ecol 79:3 (2012), 763–772.
32. 32 Chang, J.Y., Shin, S.M., Chun, J., et al. Pyrosequencing-based Molecular Monitoring of the Intestinal Bacterial Colonization in Preterm Infants. J Pediatr Gastroenterol Nutr 53:5 (2011), 512–519.
33. 33 Jacquot, A., Neveu, D., Aujoulat, F., et al. Dynamics and Clinical Evolution of Bacterial Gut Microflora in Extremely Premature Patients. J Pediatr 158:3 (2011), 390–396.
34. 34 Mangiola, F., Ianiro, G., Franceschi, F., et al. Gut microbiota in autism and mood disorders. World J Gastroenterol 22:1 (2016), 361–368.
35. 35 Claesson, M.J., Jeffery, I.B., Conde, S., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 488:7410 (2012), 178–184.
36. 36 Dinan, T.G., Cryan, J., Shanahan, F., et al. IBS: An epigenetic perspective. Nat Rev Gastroenterol Hepatol 7:8 (2010), 465–471.
37. 37 Park, S.H., Videlock, E.J., Shih, W., et al. Adverse childhood experiences are associated with irritable bowel syndrome and gastrointestinal symptom severity. Neurogastroenterol Motil 28:8 (2016), 1252–1260.
38. 38 Undseth, R., Jakobsdottir, G., Nyman, M., et al. Low serum levels of short-chain fatty acids after lactulose ingestion may indicate impaired colonic fermentation in patients with irritable bowel syndrome. Clin Exp Gastroenterol 8 (2015), 303–308.
39. 39 Kelly, J.R., Kennedy, P.J., Cryan, J.F., et al. Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders. Front Cell Neurosci, 9, 2015, 392.
40. 40 De Palma, G., Blennerhassett, P., Lu, J., et al. Microbiota and host determinants of behavioural phenotype in maternally separated mice. Nat Commun, 6, 2015, 7735.
41. 41 Jiang, H., Ling, Z., Zhang, Y., et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun 48 (2015), 186–194.
42. 42 Kelly, J.R., Borre, Y., O'Brien, C., et al. Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res 82 (2016), 109–118.
43. 43 Li, Q., Zhou, J.M., The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder. Neuroscience 324 (2016), 131–139.
44. 44 Desbonnet, L., Clarke, G., Shanahan, F., et al. Microbiota is essential for social development in the mouse. Mol Psychiatry 19:2 (2014), 146–148.
45. 45 Borre, Y.E., Moloney, R.D., Clarke, G., et al. The impact of microbiota on brain and behavior: mechanisms & therapeutic potential. Adv Exp Med Biol 817 (2014), 373–403.
46. 46 Hsiao, E.Y., McBride, S.W., Hsien, S., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155:7 (2013), 1451–1463.
47. 47 Erdman, S.E., Poutahidis, T., Probiotic ‘glow of health’: it's more than skin deep. Benef Microbes 5:2 (2014), 109–119.
48. 48 Tomova, A., Husarova, V., Lakatosova, S., et al. Gastrointestinal microbiota in children with autism in Slovakia. Physiol Behav 138 (2015), 179–187.
49. 49 Park, H., Lee, J.Y., Shin, C.M., et al. Characterization of gastrointestinal disorders in patients with parkinsonian syndromes. Parkinsonism Relat Disord 21:5 (2015), 455–460.
50. 50 Felice, V.D., Quigley, E.M., Sullivan, A.M., et al. Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms. Parkinsonism Relat Disord 27 (2016), 1–8.
51. 51 Scheperjans, F., Aho, V., Pereira, P.A., et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 30:3 (2015), 350–358.
52. 52 Dinan, T.G., Cryan, J.F., The impact of gut microbiota on brain and behaviour: implications for psychiatry. Curr Opin Clin Nutr Metab Care 18:6 (2015), 552–558.
53. 53 Dinan, T.G., Stanton, C., Cryan, J.F., Psychobiotics: a novel class of psychotropic. Biol Psychiatry 74:10 (2013), 720–726.
54. 54 Didari, T., Mozaffari, S., Nikfar, S., et al. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis. World J Gastroenterol 21:10 (2015), 3072–3084.
55. 55 Tillisch, K., Labus, J., Kilpatrick, L., et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 144:7 (2013), 1394–1401.
56. 56 Schmidt, K., Cowen, P.J., Harmer, C.J., et al. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology 232:10 (2015), 1793–1801.
57. 57 Bhagwagar, Z., Hafizi, S., Cowen, P.J., Increased salivary cortisol after waking in depression. Psychopharmacology 182:1 (2005), 54–57.
58. 58 Takada, M., Nishida, K., Kataoka-Kato, A., et al. Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models. Neurogastroenterol Motil 28:7 (2016), 1027–1036.
59. 59 Hilimire, M.R., DeVylder, J.E., Forestell, C.A., Fermented foods, neuroticism, and social anxiety: An interaction model. Psychiatry Res 228:2 (2015), 203–208.
60. 60 Steenbergen, L., Sellaro, R., van Hemert, S., et al. A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain Behav Immun 48 (2015), 258–264.
61. 61 Romijn, A.R., Rucklidge, J.J., Systematic review of evidence to support the theory of psychobiotics. Nutr Rev 73:10 (2015), 675–693.